MHRA Alert: Fake Mounjaro (tirzepatide) KwikPens
The MHRA has issued a notice regarding fake Mounjaro (tirzepatide) 15mg KwikPens dispensed by The Private Pharmacy Clinic in Birmingham. Patients with affected pens are advised to stop use immediately and report to the MHRA. The manufacturer reported five faulty pens.
Urgent
Notice
Pharmaceuticals
MHRA Approves Imlunestrant Tosylate for Breast Cancer
The MHRA has approved imlunestrant tosylate (Inluriyo), a new treatment for adult patients with a specific type of advanced or metastatic breast cancer. This approval provides a new therapeutic option for patients who have not responded to prior hormonal treatment.
Priority review
Guidance
Pharmaceuticals